Myrobalan News

Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer

Myrobalan Therapeutics Strengthens Board of Directors with Appointment of Emma Reeve

Myrobalan Presents GPR17 Antagonist Preclinical Data at ECTRIMS 2024

Myrobalan Therapeutics Names Grant Bogle to Board of Directors
